708 related articles for article (PubMed ID: 26091295)
21. CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001.
Collins SE; Jean Juste MA; Koenig SP; Secours R; Ocheretina O; Bernard D; Riviere C; Calnan M; Dunning A; Hurtado Rúa SM; Johnson WD; Pape JW; Fitzgerald DW; Severe P
Int J Tuberc Lung Dis; 2015 Jan; 19(1):50-7. PubMed ID: 25519790
[TBL] [Abstract][Full Text] [Related]
22. Incident tuberculosis and risk factors among HIV-infected children in Tanzania.
Li N; Manji KP; Spiegelman D; Muya A; Mwiru RS; Liu E; Chalamilla G; Fawzi WW; Duggan C
AIDS; 2013 May; 27(8):1273-81. PubMed ID: 23343909
[TBL] [Abstract][Full Text] [Related]
23. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2013; 8(2):e55824. PubMed ID: 23418463
[TBL] [Abstract][Full Text] [Related]
24. Incidence and Risk Factors for Overweight and Obesity after Initiation of Antiretroviral Therapy in Dar es Salaam, Tanzania.
Kintu A; Liu E; Hertzmark E; Spiegelman D; Zack RM; Muya A; Sando D; Bärnighausen T; Fawzi W
J Int Assoc Provid AIDS Care; 2018; 17():2325958218759759. PubMed ID: 29529909
[TBL] [Abstract][Full Text] [Related]
25. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
Crook AM; Turkova A; Musiime V; Bwakura-Dangarembizi M; Bakeera-Kitaka S; Nahirya-Ntege P; Thomason M; Mugyenyi P; Musoke P; Kekitiinwa A; Munderi P; Nathoo K; Prendergast AJ; Walker AS; Gibb DM;
BMC Med; 2016 Mar; 14():50. PubMed ID: 27004529
[TBL] [Abstract][Full Text] [Related]
26. Incidence of tuberculosis in HIV-infected patients receiving HAART: interaction between TST and CD4 count.
Martín-Echevarria E; Rodríguez-Zapata M; Torralba M; Fernández JM; Moreno A; Casado JL; Dronda F; Pérez-Elías MJ; Navas E; Moreno S
Int J Tuberc Lung Dis; 2011 Oct; 15(10):1347-52. PubMed ID: 22283893
[TBL] [Abstract][Full Text] [Related]
27. Incidence of tuberculosis and the need of prophylactic treatment in persons living with HIV in Stockholm during the era of anti-retroviral therapy 1996-2013.
Norrby M; Wannheden C; Ekström AM; Berggren I; Lindquist L
Infect Dis (Lond); 2018; 50(11-12):807-816. PubMed ID: 30362392
[TBL] [Abstract][Full Text] [Related]
28. Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010.
Ndlovu Z; Chirwa T; Takuva S
Pan Afr Med J; 2014; 19():114. PubMed ID: 25722787
[TBL] [Abstract][Full Text] [Related]
29. Retention in Care of Adult HIV Patients Initiating Antiretroviral Therapy in Tigray, Ethiopia: A Prospective Observational Cohort Study.
Bucciardini R; Fragola V; Abegaz T; Lucattini S; Halifom A; Tadesse E; Berhe M; Pugliese K; Binelli A; De Castro P; Terlizzi R; Fucili L; Di Gregorio M; Mirra M; Olivieri E; Teklu T; Zegeye T; Haile A; Vella S; Abraham L; Godefay H;
PLoS One; 2015; 10(9):e0136117. PubMed ID: 26340271
[TBL] [Abstract][Full Text] [Related]
30. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
[TBL] [Abstract][Full Text] [Related]
31. Incidence and determinants of tuberculosis among adults initiating antiretroviral therapy--Mozambique, 2004-2008.
Auld AF; Mbofana F; Shiraishi RW; Alfredo C; Sanchez M; Ellerbrock TV; Nelson LJ
PLoS One; 2013; 8(1):e54665. PubMed ID: 23349948
[TBL] [Abstract][Full Text] [Related]
32. Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children.
Edmonds A; Lusiama J; Napravnik S; Kitetele F; Van Rie A; Behets F
Int J Epidemiol; 2009 Dec; 38(6):1612-21. PubMed ID: 19448046
[TBL] [Abstract][Full Text] [Related]
33. Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age.
Walters E; Duvenhage J; Draper HR; Hesseling AC; Van Wyk SS; Cotton MF; Rabie H
Arch Dis Child; 2014 Nov; 99(11):998-1003. PubMed ID: 24938535
[TBL] [Abstract][Full Text] [Related]
34. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia.
Kassa A; Teka A; Shewaamare A; Jerene D
Trans R Soc Trop Med Hyg; 2012 Jun; 106(6):363-70. PubMed ID: 22521216
[TBL] [Abstract][Full Text] [Related]
35. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
[TBL] [Abstract][Full Text] [Related]
36. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
Lawn SD; Myer L; Bekker LG; Wood R
AIDS; 2006 Aug; 20(12):1605-12. PubMed ID: 16868441
[TBL] [Abstract][Full Text] [Related]
37. Predictors of antiretroviral treatment-associated tuberculosis in Ethiopia: a nested case-control study.
Mesfin N; Deribew A; Yami A; Solomon T; Van Geertruyden JP; Colebunders R
Int J STD AIDS; 2012 Feb; 23(2):94-8. PubMed ID: 22422682
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for mortality among HIV-positive patients with and without active tuberculosis in Dar es Salaam, Tanzania.
Mugusi SF; Ngaimisi E; Janabi MY; Mugusi FM; Minzi OM; Sasi PG; Bakari M; Lindquist L; Aklillu E; Sandstrom EG
Antivir Ther; 2012; 17(2):265-74. PubMed ID: 22293579
[TBL] [Abstract][Full Text] [Related]
39. Tuberculosis along the continuum of HIV care in a cohort of adolescents living with HIV in Ethiopia.
Jerene D; Abebe W; Taye K; Suarez PG; Feleke Y; Hallström I; Ruff AJ
Int J Tuberc Lung Dis; 2017 Jan; 21(1):32-37. PubMed ID: 28157462
[TBL] [Abstract][Full Text] [Related]
40. Does antiretroviral therapy reduce HIV-associated tuberculosis incidence to background rates? A national observational cohort study from England, Wales, and Northern Ireland.
Gupta RK; Rice B; Brown AE; Thomas HL; Zenner D; Anderson L; Pedrazzoli D; Pozniak A; Abubakar I; Delpech V; Lipman M
Lancet HIV; 2015 Jun; 2(6):e243-51. PubMed ID: 26423197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
